首页> 美国卫生研究院文献>Frontiers in Plant Science >Expression of the Multimeric and Highly Immunogenic Brucella spp. Lumazine Synthase Fused to Bovine Rotavirus VP8d as a Scaffold for Antigen Production in Tobacco Chloroplasts
【2h】

Expression of the Multimeric and Highly Immunogenic Brucella spp. Lumazine Synthase Fused to Bovine Rotavirus VP8d as a Scaffold for Antigen Production in Tobacco Chloroplasts

机译:多聚体和高度免疫原性布鲁氏菌属的表达。 Lumazine合酶融合到牛轮状病毒VP8d中作为烟草叶绿体抗原产生的支架。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lumazine synthase from Brucella spp. (BLS) is a highly immunogenic decameric protein which can accommodate foreign polypeptides or protein domains fused to its N-termini, markedly increasing their immunogenicity. The inner core domain (VP8d) of VP8 spike protein from bovine rotavirus is responsible for viral adhesion to sialic acid residues and infection. It also displays neutralizing epitopes, making it a good candidate for vaccination. In this work, the BLS scaffold was assessed for the first time in plants for recombinant vaccine development by N-terminally fusing BLS to VP8d and expressing the resulting fusion (BLSVP8d) in tobacco chloroplasts. Transplastomic plants were obtained and characterized by Southern, northern and western blot. BLSVP8d was highly expressed, representing 40% of total soluble protein (4.85 mg/g fresh tissue). BLSVP8d remained soluble and stable during all stages of plant development and even in lyophilized leaves stored at room temperature. Soluble protein extracts from fresh and lyophilized leaves were able to induce specific neutralizing IgY antibodies in a laying hen model. This work presents BLS as an interesting platform for highly immunogenic injectable, or even oral, subunit vaccines. Lyophilization of transplastomic leaves expressing stable antigenic fusions to BLS would further reduce costs and simplify downstream processing, purification and storage, allowing for more practical vaccines.
机译:来自布鲁氏菌属的Lumazine合酶。 (BLS)是一种高度免疫原性的十聚体蛋白,可以容纳与其N末端融合的外源多肽或蛋白结构域,从而显着提高其免疫原性。来自牛轮状病毒的VP8穗蛋白的内核结构域(VP8d)负责病毒对唾液酸残基的粘附和感染。它还显示中和的表位,使其成为疫苗接种的良好候选者。在这项工作中,通过在N末端将BLS融合到VP8d并在烟草叶绿体中表达最终的融合蛋白(BLSVP8d),首次在植物中评估了BLS支架的重组疫苗开发。获得了转质体植物,并通过Southern,Northern和western印迹对其进行了表征。 BLSVP8d高表达,占总可溶性蛋白的40%(4.85 mg / g新鲜组织)。 BLSVP8d在植物发育的所有阶段甚至在室温下冻干的叶片中都保持可溶性和稳定状态。新鲜和冻干的叶中的可溶性蛋白提取物能够在蛋鸡模型中诱导特异性中和性IgY抗体。这项工作将BLS展示为高度免疫原性可注射甚至口服亚单位疫苗的有趣平台。表达稳定的BLS抗原融合体的质体叶冻干将进一步降低成本,简化下游加工,纯化和储存,从而可提供更实用的疫苗。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号